LEADER 05130nam 22004935 450 001 9910298395603321 005 20200705081550.0 010 $a3-319-90755-7 024 7 $a10.1007/978-3-319-90755-0 035 $a(CKB)4100000005471751 035 $a(MiAaPQ)EBC5488830 035 $a(DE-He213)978-3-319-90755-0 035 $a(PPN)22991747X 035 $a(EXLCZ)994100000005471751 100 $a20180806d2018 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$a3D Printing of Pharmaceuticals /$fedited by Abdul W. Basit, Simon Gaisford 205 $a1st ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (246 pages) 225 1 $aAAPS Advances in the Pharmaceutical Sciences Series,$x2210-7371 ;$v31 311 $a3-319-90754-9 327 $aParadigm of personalised medicines -- Pharmaceutical ink-jet printing -- Fused-deposition modelling (FDM) 3D printing -- Stereolithographic (SLA) 3D printing -- Selective laser sintering (SLS) 3D printing -- Flexographic 3D printing -- Semi-solid extrusion 3D printing -- Ink-jet printing for personalised dosing -- Printing crystal forms -- Printing of nanoparticle/polymer conjugates -- 3D Printing organ vasculature -- 3D printed ears -- Visualisation of 3D printed compartmental DDSs -- 3D printed medicines - A regulatory perspective -- Spritam ? a case study -- 4D printing -- 3DP ? costs and manufacturing issues -- Other non-pharmaceutical 3DP areas. 330 $a3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Professor Abdul Basit is a Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul's research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. His research has been translated into the design of new technologies and improved disease treatments, many of which have been commercialised. Abdul is also a serial entrepreneur and has filed multiple patents, is the recepient of several research awards and has founded 3 companies (Kuecept, Intract Pharma, FabRx). He further serves as a consultant to many pharmaceutical organisations and is on the advisory boards of scientific journals, healthcare and charitable bodies. Professor Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters, 4 authored books and is the recipient of multiple research awards. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, translating his expertise by co-founding FabRx. Simon is also an expert in the physicochemical characterisation of compounds and formulations with thermal methods and calorimetry. 410 0$aAAPS Advances in the Pharmaceutical Sciences Series,$x2210-7371 ;$v31 606 $aPharmaceutical technology 606 $aBiomedical engineering 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aBiomedical Engineering/Biotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/B24000 615 0$aPharmaceutical technology. 615 0$aBiomedical engineering. 615 14$aPharmaceutical Sciences/Technology. 615 24$aBiomedical Engineering/Biotechnology. 676 $a338.476151 702 $aBasit$b Abdul W$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGaisford$b Simon$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910298395603321 996 $a3D Printing of Pharmaceuticals$92526766 997 $aUNINA